Christine N Galinski1, Jeffrey I Zwicker2, Daniel R Kennedy1. 1. Department of Pharmaceutical and Administrative Sciences, College of Pharmacy, Western New England University, United States. 2. Division of Hemostasis and Thrombosis, Beth Israel Deaconess Medical Center, Harvard Medical School, United States.
Abstract
INTRODUCTION: Although epidemiologic evidence points to cardioprotective activity of red wine, the mechanistic basis for antithrombotic activity has not been established. Quercetin and related flavonoids are present in high concentrations in red but not white wine. Quercetin-glycosides were recently shown to prevent thrombosis in animal models through the inhibition of extracellular protein disulfide isomerase (PDI). We evaluated whether red or white wine inhibited PDI activity in vitro. METHODS: Quercetin levels in red and white wines were measured by HPLC analysis. Inhibition of PDI activity by red and white wines was assessed by an insulin reduction turbidity assay at various concentrations of wine. PDI inhibition was confirmed using a reduced peptide that contained a disulfide containing peptide as a substrate. The inhibition of PDI related thiol isomerases ERp5 and ERp57 was also assessed. RESULTS: We observed a dose-dependent decrease of PDI activity for a variety of red but not white wines. Red wine diluted to 3% final concentration resulted in over 80% inhibition of PDI activity by insulin reductase assay for all varieties tested. This inhibition was also observed in the peptide based assay. Red grape juice yielded similar results but ethanol alone did not affect PDI activity. Interestingly, red wine also inhibited the PDI related thiol isomerases ERp5 and ERp57, albeit to a lesser degree than PDI. CONCLUSIONS: PDI activity is inhibited by red wine and grape juice, identifying a potentially novel mechanism underlying the cardiovascular benefits attributed to wine consumption.
INTRODUCTION: Although epidemiologic evidence points to cardioprotective activity of red wine, the mechanistic basis for antithrombotic activity has not been established. Quercetin and related flavonoids are present in high concentrations in red but not white wine. Quercetin-glycosides were recently shown to prevent thrombosis in animal models through the inhibition of extracellular protein disulfide isomerase (PDI). We evaluated whether red or white wine inhibited PDI activity in vitro. METHODS:Quercetin levels in red and white wines were measured by HPLC analysis. Inhibition of PDI activity by red and white wines was assessed by an insulin reduction turbidity assay at various concentrations of wine. PDI inhibition was confirmed using a reduced peptide that contained a disulfide containing peptide as a substrate. The inhibition of PDI related thiol isomerases ERp5 and ERp57 was also assessed. RESULTS: We observed a dose-dependent decrease of PDI activity for a variety of red but not white wines. Red wine diluted to 3% final concentration resulted in over 80% inhibition of PDI activity by insulin reductase assay for all varieties tested. This inhibition was also observed in the peptide based assay. Red grape juice yielded similar results but ethanol alone did not affect PDI activity. Interestingly, red wine also inhibited the PDI related thiol isomerases ERp5 and ERp57, albeit to a lesser degree than PDI. CONCLUSIONS:PDI activity is inhibited by red wine and grape juice, identifying a potentially novel mechanism underlying the cardiovascular benefits attributed to wine consumption.
Authors: J E Freedman; C Parker; L Li; J A Perlman; B Frei; V Ivanov; L R Deak; M D Iafrati; J D Folts Journal: Circulation Date: 2001-06-12 Impact factor: 29.690
Authors: Jasimuddin Ahamed; Henri H Versteeg; Marjolein Kerver; Vivien M Chen; Barbara M Mueller; Philip J Hogg; Wolfram Ruf Journal: Proc Natl Acad Sci U S A Date: 2006-09-07 Impact factor: 11.205
Authors: John A Polagruto; Heidrun B Gross; Faranak Kamangar; Ken-Ichi Kosuna; Buxiang Sun; Hajime Fujii; Carl L Keen; Robert M Hackman Journal: J Med Food Date: 2007-12 Impact factor: 2.786
Authors: M G Hertog; D Kromhout; C Aravanis; H Blackburn; R Buzina; F Fidanza; S Giampaoli; A Jansen; A Menotti; S Nedeljkovic Journal: Arch Intern Med Date: 1995-02-27
Authors: José A Guerrero; Leyre Navarro-Nuñez; María L Lozano; Constantino Martínez; Vicente Vicente; Jonathan M Gibbins; José Rivera Journal: Br J Clin Pharmacol Date: 2007-04-10 Impact factor: 4.335
Authors: Dylan Krajewski; Stephanie H Polukort; Justine Gelzinis; Jeffrey Rovatti; Edwin Kaczenski; Christine Galinski; Megan Pantos; Nickul N Shah; Sallie S Schneider; Daniel R Kennedy; Clinton B Mathias Journal: Front Immunol Date: 2020-12-22 Impact factor: 7.561
Authors: Jessica Guyette; Patrick Cherubin; Albert Serrano; Michael Taylor; Faisal Abedin; Morgan O'Donnell; Helen Burress; Suren A Tatulian; Ken Teter Journal: Toxins (Basel) Date: 2019-08-04 Impact factor: 4.546